Medifast
MED
168 hedge funds and large institutions have $616M invested in Medifast in 2017 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 54 increasing their positions, 63 reducing their positions, and 18 closing their positions.
63% more call options, than puts
Call options by funds: $2.01M | Put options by funds: $1.24M
39% more capital invested
Capital invested by funds: $443M → $616M (+$173M)
39% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 18
4% more funds holding
Funds holding: 161 → 168 (+7)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2.57% less ownership
Funds ownership: 89.48% → 86.91% (-2.6%)
14% less repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 63
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$5.98M |
| 2 |
American Century Companies
Kansas City,
Missouri
|
+$5.67M |
| 3 |
JP Morgan Chase
New York
|
+$5.41M |
| 4 |
Principal Financial Group
Des Moines,
Iowa
|
+$3.72M |
| 5 |
Millennium Management
New York
|
+$2.78M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$6.1M |
| 2 |
DIA
Dean Investment Associates
Beavercreek,
Ohio
|
-$4.27M |
| 3 |
PRCP
Pacific Ridge Capital Partners
Lake Oswego,
Oregon
|
-$4.21M |
| 4 |
Allianz Asset Management
Munich,
Germany
|
-$3.69M |
| 5 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
-$3.05M |
MED Hedge Fund Activity: Q3 2017 in Review
168 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Medifast (MED) for Q3 2017, worth a combined $616M — up 39% from $443M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new MED positions and 18 closed out — a net gain of 7 holders — while 54 added to existing stakes and 63 trimmed.
The largest buyer was BlackRock, adding an estimated $5.98M. The largest seller was Kennedy Capital Management, cutting an estimated $6.1M.
- 168 institutional investors held Medifast (MED) as of Q3 2017, up from 161 in Q2 2017.
- Funds reported $616M of Medifast stock for Q3 2017, up 39% quarter-over-quarter.
- 25 funds opened new Medifast positions in Q3 2017 and 18 closed out, a net change of +7 holders.
- The largest Medifast buyer in Q3 2017 was BlackRock, an estimated $5.98M added.
- The largest Medifast seller in Q3 2017 was Kennedy Capital Management, an estimated $6.1M sold.
Based on aggregated 13F filings for Q3 2017.